Returns as of 6/17/2021
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Evoke Pharma Inc is engaged in the development of drugs to treat gastrointestinal disorders and diseases. Its product candidate EVK-001 is in late stage clinical testing.
There is no available coverage of Evoke Pharma at this time.
of CAPS members think EVOK will outperform the market
What Fools think
420 Stevens Avenue Suite 370
Solana Beach, CA 92075